How the brain contributes to mental and physical fatigue
Official title: Investigating Fundamental Mechanisms of Mental and Physical Fatigue Using Neurotransmitter Reuptake Inhibitors and Electroencephalography: a Randomized Counterbalanced Crossover Trial
Run by Vrije Universiteit Brussel · NCT05880342 · Data updated 2026-11-12
This trial tests whether two drugs that change brain chemicals—methylphenidate and reboxetine—alter how healthy, physically active adults feel and perform during mental and physical fatigue.
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 35 Years |
| Sex | All |
| Enrollment | 62 (estimated) |
| Sponsor | Vrije Universiteit Brussel Academic / other |
| Locations | 1 site (Brussels, Brussels Capital) |
| Status | Recruiting |
| Started | May 3, 2023 |
| Main results expected | December 31, 2025 |
| Study ends | December 31, 2025 |
| Registry record updated | June 18, 2025 |
| Trial ID | NCT05880342 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal participants are healthy adults who exercise at least once weekly, are non-smokers, free of chronic health or psychiatric conditions, not taking medications (aside from contraceptives), and available for multiple lab visits in Brussels.
✕Probably not a fit
People with chronic fatigue disorders, active psychiatric illness, recent injuries, pregnancy, important food intolerances, smokers, or those already taking relevant medications are unlikely to benefit or qualify.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Researchers will enroll healthy, trained adults and use a randomized, single-blind, placebo-controlled, counterbalanced crossover design to compare methylphenidate, reboxetine, and placebo across three experiments (physical fatigue, mental fatigue, and combined fatigue). During each session they will measure brain activation, fatigue perception, and neuromuscular efficiency with neurophysiological techniques before and after induced fatigue. The crossover design lets each participant serve as their own control to isolate drug effects on fatigue onset and brain activity. Participants with high baseline fatigue, burnout, psychiatric disorders, recent injuries, or certain medication use will be excluded to focus on healthy responses.
Why it matters
Potential benefit: If successful, the results could point to brain chemical targets for reducing perceived and performance-related fatigue and inform treatments for fatigue-related conditions.
How similar studies have gone: Prior research links dopamine and noradrenaline to fatigue and shows some benefit of stimulants in reducing fatigue in clinical settings, but applying these drugs to induced exercise and mental fatigue with detailed brain measures is relatively novel and evidence is mixed.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Healthy trained individuals (exercises at least 1x per week, no neurological, cardiovascular internal or musculoskeletal disorders of any kind) * No use of chronic or occasional prescribed medication (except for contraceptives) * Non-smoker Exclusion Criteria: * Injuries of any kind in the past 6 months * Pregnancy * Specific food or drink allergies (e.g. lactose and/or gluten intolerance) * Suffering from a chronic health condition (could be neurological, cardiovascular, internal and musculoskeletal) * Participating in any concomitant care or research trials * History of suffering from any mental/psychiatric disorders: Suffering from a higher risk of burn out, indicated by a total score of more than 2.59 on the Burn out assessment tool (BAT) Suffering from high general fatigue, indicated by a score of more than 57 on the Multidimensional fatigue inventory (MFI) Suffering from depression, indicated by a score of more than16 on the Beck depression inventory-II (BDI-II) * Use of medication Chronic use with an exception for contraceptives Prescribed medication in between or before trials Use of non-prescribed occasional medication 24 hours prior each trial * Use of caffeine and heavy efforts 24 hours prior each trial * Suffering from colour vision deficiencies * Not eating a standardized meal, the morning of each trial
Where it's running
-
Brussels Labo voor Inspanning & Topsport U-residence
Brussels, Brussels Capital, Belgium Recruiting
Study contacts
- Study coordinator: Yahaira Laurisa Arenales Arauz, Msc
- Email: laurisa.arenales@vub.be
- Phone: +31615076269
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Remote Ischaemic Conditioning for Fatigue After Stroke 2
Aat least 12 weeks after stroke, adults with post-stroke fatigue will try a simple hand-arm cuff treatment at home to see if it helps reduce fatigue.
-
Micro-choice-based approach to fatigue management
A small study in Basel will test a new four-day group program using micro-choices to help people with fatigue from multiple causes see if it’s doable, acceptable, and may help daily functioning.
-
HBS-301 for Narcolepsy: daily wakefulness and sleepiness improvement in adults
This Phase 3 study tests HBS-301 vs placebo in adults with narcolepsy to see if it helps with daytime sleepiness, cataplexy, sleepiness, and fatigue.
-
See if Nuvastatic helps with cancer-related fatigue in colon cancer patients on first-line chemotherapy
This trial tests whether Nuvastatic can lessen fatigue in adults with colon cancer who are receiving their first round of chemotherapy, compared to placebo.
-
Balance and gait in multiple sclerosis: linking motion data to function
Researchers will see if precise motion measurements of balance and walking relate to everyday functional tests in adults with MS.
-
Relaxation and breathing techniques to help with breathlessness and tiredness in cancer patients in palliative care
This study tests whether progressive muscle relaxation or deep breathing exercises can reduce dyspnea and fatigue and improve self-care in adults with cancer receiving palliative care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.